Browsing Centre for Clinical Pharmacology by Author "PSORT Consortium"
Now showing items 1-2 of 2
-
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
Andres-Ejarque, R; Ale, HB; Grys, K; Tosi, I; Solanky, S; Ainali, C; Catak, Z; Sreeneebus, H; Saklatvala, J; Dand, N (2021-12-16) -
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.
Foulkes, AC; Watson, DS; Carr, DF; Kenny, JG; Slidel, T; Parslew, R; Pirmohamed, M; PSORT Consortium; Anders, S; Reynolds, NJ (2019-01)Biologic therapies have shown high efficacy in psoriasis, but individual response varies and is poorly understood. To inform biomarker discovery in the Psoriasis Stratification to Optimise Relevant Therapy (i.e., PSORT) ...